Health Care & Life Sciences » Pharmaceuticals » Top pharmaceutical drugs | Top psychiatric drugs U.S. revenue 2016

Top psychiatric drugs in the United States by sales 2016

Selected top psychiatric drugs' U.S. revenue in 2016 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data shows the some of the best-selling psychiatric drugs in the U.S. during 2016. During this period, Lyrica generated a revenue of some 4.4 billion USD. Lyrica is an anticonvulsant drug marketed by Pfizer. In the U.S., it is most commonly used for neuropathic pain.

Lyrica	4400
Vyvanse	3100
Invega Sustenna	1304
Latuda	1286
Cymbalta	930.5
Abilify	878
Namenda	682
Seroquel XR	633
Pristiq	516

Top psychiatric drugs in the United States by sales 2016

StatInvestor